The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
First Affiliated Hospital of Wenzhou Medical University
First Affiliated Hospital of Wenzhou Medical University
National Institutes of Health Clinical Center (CC)
Duke University
ChineseAMS
Duke University
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Rochester
M.D. Anderson Cancer Center
Duke University
University of Manitoba
GlaxoSmithKline